Advancing Imaging to Enhance Surgery : From Image to Information Guidance - 20/11/20
, Egesta Lopci, MD, PhD c , Lorenzo G. Gay, MD b, d, Marco Conti Nibali, MD b, d , Marco Rossi, MD b, d, Tommaso Sciortino, MD b, d, Antonella Castellano, MD, PhD e , Lorenzo Bello, MD b, dRésumé |
Conventional magnetic resonance imaging (cMRI) has an established role as a crucial disease parameter in the multidisciplinary management of glioblastoma, guiding diagnosis, treatment planning, assessment, and follow-up. Yet, cMRI cannot provide adequate information regarding tissue heterogeneity and the infiltrative extent beyond the contrast enhancement. Advanced magnetic resonance imaging and PET and newer analytical methods are transforming images into data (radiomics) and providing noninvasive biomarkers of molecular features (radiogenomics), conveying enhanced information for improving decision making in surgery. This review analyzes the shift from image guidance to information guidance that is relevant for the surgical treatment of glioblastoma.
Le texte complet de cet article est disponible en PDF.Keywords : Glioblastoma, Surgery, Magnetic resonance imaging (MRI), PET, Presurgical planning, Image guidance, Radiomics
Plan
Vol 32 - N° 1
P. 31-46 - janvier 2021 Retour au numéro
Article précédent
- Extent of Resection of Glioblastoma : A Critical Evaluation in the Molecular Era
- Daniel P. Cahill
- Intraoperative Imaging for High-Grade Glioma Surgery
- Thomas Noh, Martina Mustroph, Alexandra J. Golby
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?